Glenmark Pharmaceuticals has informed that it enclosed press release titled ‘Glenmark Launches Winlevi® (clascoterone) 10 mg/g cream in Key European Markets for the Treatment of Acne Vulgaris’.
The above information is a part of company’s filings submitted to BSE.